Skip to main content

Advertisement

Open Peer Review Reports for: Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
7 Feb 2017 Submitted Original manuscript
22 May 2017 Reviewed Reviewer Report - Leonard R Krilov
10 Jun 2017 Reviewed Reviewer Report - Bernhard Resch
12 Jul 2017 Author responded Author comments - M Sanchez-Luna
Resubmission - Version 2
12 Jul 2017 Submitted Manuscript version 2
14 Jul 2017 Reviewed Reviewer Report - Bernhard Resch
13 Aug 2017 Reviewed Reviewer Report - Leonard R Krilov
21 Sep 2017 Author responded Author comments - M Sanchez-Luna
Resubmission - Version 3
21 Sep 2017 Submitted Manuscript version 3
Publishing
6 Oct 2017 Editorially accepted
17 Oct 2017 Article published 10.1186/s12879-017-2803-0

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement